We are live on ! Find out more
MBIO icon

Mustang Bio
MBIO

36 hedge funds and large institutions have $15.8M invested in Mustang Bio in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 6

0% more funds holding

Funds holding: 36 → 36 (0)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

12% less capital invested

Capital invested by funds: $17.9M → $15.8M (-$2.09M)

Holders
36
Holders Change
–
Holders Change %
0%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
6
Closed
5
Calls
$215K
Puts
–
Net Calls
+$215K
Net Calls Change
-$34K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$315K
2
BlackRock
BlackRock
New York
+$230K
3
State Street
State Street
Massachusetts
+$110K
4
Citadel Advisors
Citadel Advisors
Florida
+$105K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$90K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$378K
2
SIM
Spark Investment Management
New York
-$217K
3
Squarepoint
Squarepoint
New York
-$81K
4
TCIM
TIAA CREF Investment Management
New York
-$40K
5
PPA
Parametric Portfolio Associates
Washington
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$4.88M +$230K +46 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.88M -$20K -4 -0.5%
State Street
3
State Street
Massachusetts
$1.45M +$110K +22 +7%
Northern Trust
4
Northern Trust
Illinois
$1.07M +$15K +3 +1%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$972K +$90K +18 +9%
Morgan Stanley
6
Morgan Stanley
New York
$492K +$315K +63 +134%
BCM
7
Bridgeway Capital Management
Texas
$446K – – –
BRWA
8
B. Riley Wealth Advisors
Florida
$433K +$10K +2 +2%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$260K – – –
Deutsche Bank
10
Deutsche Bank
Germany
$224K +$35K +7 +16%
Charles Schwab
11
Charles Schwab
California
$187K – – –
California State Teachers Retirement System (CalSTRS)
12
California State Teachers Retirement System (CalSTRS)
California
$152K – – –
FWM
13
Frontier Wealth Management
Missouri
$152K – – –
TA
14
Teachers Advisors
New York
$121K – – –
PPA
15
Parametric Portfolio Associates
Washington
$119K -$30K -6 -18%
TCIM
16
TIAA CREF Investment Management
New York
$117K -$40K -8 -24%
Wells Fargo
17
Wells Fargo
California
$108K – – –
New York State Common Retirement Fund
18
New York State Common Retirement Fund
New York
$97K -$10K -2 -8%
Citadel Advisors
19
Citadel Advisors
Florida
$93K +$105K +21 New
RhumbLine Advisers
20
RhumbLine Advisers
Massachusetts
$79K -$5K -1 -5%
AIG
21
American International Group
New York
$64K – – –
UBS Group
22
UBS Group
Switzerland
$63K +$55K +11 +367%
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$60K – – –
Envestnet Asset Management
24
Envestnet Asset Management
Illinois
$60K +$65K +13 New
MAM
25
Meeder Asset Management
Ohio
$46K +$45K +9 +900%
1
2

MBIO Hedge Fund Activity: Q3 2018 in Review

36 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q3 2018, worth a combined $15.8M — down 12% from $17.9M a quarter earlier.

Fund positioning in MBIO was balanced in Q3 2018: 5 funds opened new positions, 5 closed out, 12 added to existing stakes and 6 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $315K. The largest seller was Goldman Sachs, exiting entirely with an estimated $378K sold.

  • 36 institutional investors held Mustang Bio (MBIO) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $15.8M of Mustang Bio stock for Q3 2018, down 12% quarter-over-quarter.
  • 5 funds opened new Mustang Bio positions in Q3 2018 and 5 closed out, a net change of 0 holders.
  • The largest Mustang Bio buyer in Q3 2018 was Morgan Stanley, an estimated $315K added.
  • The largest Mustang Bio seller in Q3 2018 was Goldman Sachs, an estimated $378K sold.

Based on aggregated 13F filings for Q3 2018.